These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36590707)

  • 1. MOLER: Incorporate Molecule-Level Reward to Enhance Deep Generative Model for Molecule Optimization.
    Fu T; Xiao C; Glass LM; Sun J
    IEEE Trans Knowl Data Eng; 2022 Nov; 34(11):5459-5471. PubMed ID: 36590707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular substructure tree generative model for de novo drug design.
    Wang S; Song T; Zhang S; Jiang M; Wei Z; Li Z
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MERMAID: an open source automated hit-to-lead method based on deep reinforcement learning.
    Erikawa D; Yasuo N; Sekijima M
    J Cheminform; 2021 Nov; 13(1):94. PubMed ID: 34838134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Deep Generative Model for Molecule Optimization via One Fragment Modification.
    Chen Z; Min MR; Parthasarathy S; Ning X
    Nat Mach Intell; 2021 Dec; 3(12):1040-1049. PubMed ID: 35187404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Generative Models in
    Pang C; Qiao J; Zeng X; Zou Q; Wei L
    J Chem Inf Model; 2024 Apr; 64(7):2174-2194. PubMed ID: 37934070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models.
    Xie W; Wang F; Li Y; Lai L; Pei J
    J Chem Inf Model; 2022 May; 62(10):2269-2279. PubMed ID: 35544331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing an Improved Cycle Architecture for AI-Based Generation of New Structures Aimed at Drug Discovery.
    Zhang C; Xie L; Lu X; Mao R; Xu L; Xu X
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mol-CycleGAN: a generative model for molecular optimization.
    Maziarka Ł; Pocha A; Kaczmarczyk J; Rataj K; Danel T; Warchoł M
    J Cheminform; 2020 Jan; 12(1):2. PubMed ID: 33431006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explore drug-like space with deep generative models.
    Wang J; Mao J; Wang M; Le X; Wang Y
    Methods; 2023 Feb; 210():52-59. PubMed ID: 36682423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On failure modes in molecule generation and optimization.
    Renz P; Van Rompaey D; Wegner JK; Hochreiter S; Klambauer G
    Drug Discov Today Technol; 2019 Dec; 32-33():55-63. PubMed ID: 33386095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of reinforcement learning in transformer-based molecular design.
    He J; Tibo A; Janet JP; Nittinger E; Tyrchan C; Czechtizky W; Engkvist O
    J Cheminform; 2024 Aug; 16(1):95. PubMed ID: 39118113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo molecular design with deep molecular generative models for PPI inhibitors.
    Wang J; Chu Y; Mao J; Jeon HN; Jin H; Zeb A; Jang Y; Cho KH; Song T; No KT
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based
    Li Y; Pei J; Lai L
    Chem Sci; 2021 Oct; 12(41):13664-13675. PubMed ID: 34760151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cMolGPT: A Conditional Generative Pre-Trained Transformer for Target-Specific De Novo Molecular Generation.
    Wang Y; Zhao H; Sciabola S; Wang W
    Molecules; 2023 May; 28(11):. PubMed ID: 37298906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving
    Wang F; Feng X; Guo X; Xu L; Xie L; Chang S
    Front Genet; 2021; 12():709500. PubMed ID: 34422013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network-principled deep generative models for designing drug combinations as graph sets.
    Karimi M; Hasanzadeh A; Shen Y
    Bioinformatics; 2020 Jul; 36(Suppl_1):i445-i454. PubMed ID: 32657357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep generative design with 3D pharmacophoric constraints.
    Imrie F; Hadfield TE; Bradley AR; Deane CM
    Chem Sci; 2021 Nov; 12(43):14577-14589. PubMed ID: 34881010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Simple Way to Incorporate Target Structural Information in Molecular Generative Models.
    Zhang W; Zhang K; Huang J
    J Chem Inf Model; 2023 Jun; 63(12):3719-3730. PubMed ID: 37318828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.